Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM012 tablets dose-finding and non-inferiority trial in mild Alzheimer's disease
KCT0007443Phase 3Recruiting
- Sponsor
- Mediforum
- Start
- Nov 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of PM012 in Alzheimer's disease (AD) (2 arms), sponsored by Mediforum. Started Nov 2020; status: recruiting.
02
Drugs
PM012
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on KCT0007443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007443.